Stock Watch:

Biotech's Next Big Thing -- ASCO II

TheStreet.com Videos 2:20 mins

TheStreet senior columnist Adam Feuerstein discusses the winners and losers from the research abstracts ahead of the ASCO cancer conference.

View Comments (0)